Last 12 months
Inside the activity.
2 purchase rows · 26 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 15 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 2 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 23, 2025 Filed Jun 25, 2025 01:35 UTC |
Cline Darren SChief Commercial Officer
|
GrantShare Option (Right to Buy) · Derivative | 185,800 | $0.00 Strike: $31.49 | $0.00 |
DisclosureSEC source: 0000950170-25-089721 · ownership.xml · derivative · entry 1 Cline Darren S · CIK 0001633639 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,800 Underlying: Common Shares · 185,800 shares Expires 2035-06-22 F1 · derivative.exercise_date: Vesting 25% on June 23, 2026, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 21:59 UTC |
Gover Justin D.Director
|
GrantRestricted Share Units · Derivative | 2,645 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-083325 · ownership.xml · derivative · entry 2 Gover Justin D. · CIK 0001754129 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,645 Underlying: Common Shares · 2,645 shares Expires not disclosed F2 · derivative.exercise_date: Each restricted share unit represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 4, 2026 or (ii) the day before the date of the issuer's 2026 annual meeting of shareholders. F2 · derivative.expiration_date: Each restricted share unit represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 4, 2026 or (ii) the day before the date of the issuer's 2026 annual meeting of shareholders. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 21:59 UTC |
Gover Justin D.Director
|
GrantShare Option (Right to Buy) · Derivative | 17,012 | $0.00 Strike: $30.73 | $0.00 |
DisclosureSEC source: 0000950170-25-083325 · ownership.xml · derivative · entry 1 Gover Justin D. · CIK 0001754129 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,012 Underlying: Common Shares · 17,012 shares Expires 2035-06-04 F1 · derivative.exercise_date: Vesting 100% on the earlier of (i) June 4, 2026 or (ii) the day before the date of the issuer's 2026 annual meeting of shareholders. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 21:58 UTC |
GANNON STEVENDirector
|
GrantRestricted Share Units · Derivative | 2,645 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-083321 · ownership.xml · derivative · entry 3 GANNON STEVEN · CIK 0001643085 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,645 Underlying: Common Shares · 2,645 shares Expires not disclosed F3 · derivative.exercise_date: Each restricted share unit represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 4, 2026 or (ii) the day before the date of the issuer's 2026 annual meeting of shareholders. F3 · derivative.expiration_date: Each restricted share unit represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 4, 2026 or (ii) the day before the date of the issuer's 2026 annual meeting of shareholders. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 21:58 UTC |
GANNON STEVENDirector
|
GrantShare Option (Right to Buy) · Derivative | 17,012 | $0.00 Strike: $30.73 | $0.00 |
DisclosureSEC source: 0000950170-25-083321 · ownership.xml · derivative · entry 2 GANNON STEVEN · CIK 0001643085 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,012 Underlying: Common Shares · 17,012 shares Expires 2035-06-04 F2 · derivative.exercise_date: Vesting 100% on the earlier of (i) June 4, 2026 or (ii) the day before the date of the issuer's 2026 annual meeting of shareholders. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 21:58 UTC |
GANNON STEVENDirector
|
SaleCommon Shares | 3 | $30.48 | $91.44 |
DisclosureSEC source: 0000950170-25-083321 · ownership.xml · nonDerivative · entry 1 GANNON STEVEN · CIK 0001643085 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,141 F1 · shares: Shares automatically sold in payment of transfer fee for transfer of shares to an alternate brokerage account. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 22:00 UTC |
PATOU GARYDirector
|
GrantRestricted Share Units · Derivative | 2,645 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-083329 · ownership.xml · derivative · entry 2 PATOU GARY · CIK 0001283535 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,645 Underlying: Common Shares · 2,645 shares Expires not disclosed F2 · derivative.exercise_date: Each restricted share unit represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 4, 2026 or (ii) the day before the date of the issuer's 2026 annual meeting of shareholders. F2 · derivative.expiration_date: Each restricted share unit represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 4, 2026 or (ii) the day before the date of the issuer's 2026 annual meeting of shareholders. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 22:00 UTC |
PATOU GARYDirector
|
GrantShare Option (Right to Buy) · Derivative | 17,012 | $0.00 Strike: $30.73 | $0.00 |
DisclosureSEC source: 0000950170-25-083329 · ownership.xml · derivative · entry 1 PATOU GARY · CIK 0001283535 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,012 Underlying: Common Shares · 17,012 shares Expires 2035-06-04 F1 · derivative.exercise_date: Vesting 100% on the earlier of (i) June 4, 2026 or (ii) the day before the date of the issuer's 2026 annual meeting of shareholders. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 22:00 UTC |
Machado PatrickDirector
|
GrantRestricted Share Units · Derivative | 2,645 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-083328 · ownership.xml · derivative · entry 2 Machado Patrick · CIK 0001311210 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,645 Underlying: Common Shares · 2,645 shares Expires not disclosed F2 · derivative.exercise_date: Each restricted share unit represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 4, 2026 or (ii) the day before the date of the issuer's 2026 annual meeting of shareholders. F2 · derivative.expiration_date: Each restricted share unit represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 4, 2026 or (ii) the day before the date of the issuer's 2026 annual meeting of shareholders. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 22:00 UTC |
Machado PatrickDirector
|
GrantShare Option (Right to Buy) · Derivative | 17,012 | $0.00 Strike: $30.73 | $0.00 |
DisclosureSEC source: 0000950170-25-083328 · ownership.xml · derivative · entry 1 Machado Patrick · CIK 0001311210 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,012 Underlying: Common Shares · 17,012 shares Expires 2035-06-04 F1 · derivative.exercise_date: Vesting 100% on the earlier of (i) June 4, 2026 or (ii) the day before the date of the issuer's 2026 annual meeting of shareholders. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 21:57 UTC |
Svoronos DawnDirector
|
GrantRestricted Share Units · Derivative | 2,645 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-083317 · ownership.xml · derivative · entry 2 Svoronos Dawn · CIK 0001574579 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,645 Underlying: Common Shares · 2,645 shares Expires not disclosed F2 · derivative.exercise_date: Each restricted share unit represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 4, 2026 or (ii) the day before the date of the issuer's 2026 annual meeting of shareholders. F2 · derivative.expiration_date: Each restricted share unit represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 4, 2026 or (ii) the day before the date of the issuer's 2026 annual meeting of shareholders. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 21:57 UTC |
Svoronos DawnDirector
|
GrantShare Option (Right to Buy) · Derivative | 17,012 | $0.00 Strike: $30.73 | $0.00 |
DisclosureSEC source: 0000950170-25-083317 · ownership.xml · derivative · entry 1 Svoronos Dawn · CIK 0001574579 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,012 Underlying: Common Shares · 17,012 shares Expires 2035-06-04 F1 · derivative.exercise_date: Vesting 100% on the earlier of (i) June 4, 2026 or (ii) the day before the date of the issuer's 2026 annual meeting of shareholders. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 21:59 UTC |
GAROFALO ELIZABETH A.Director
|
GrantRestricted Share Units · Derivative | 2,645 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-083323 · ownership.xml · derivative · entry 2 GAROFALO ELIZABETH A. · CIK 0001826361 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,645 Underlying: Common Shares · 2,645 shares Expires not disclosed F2 · derivative.exercise_date: Each restricted share unit represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 4, 2026 or (ii) the day before the date of the issuer's 2026 annual meeting of shareholders. F2 · derivative.expiration_date: Each restricted share unit represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 4, 2026 or (ii) the day before the date of the issuer's 2026 annual meeting of shareholders. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 21:59 UTC |
GAROFALO ELIZABETH A.Director
|
GrantShare Option (Right to Buy) · Derivative | 17,012 | $0.00 Strike: $30.73 | $0.00 |
DisclosureSEC source: 0000950170-25-083323 · ownership.xml · derivative · entry 1 GAROFALO ELIZABETH A. · CIK 0001826361 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,012 Underlying: Common Shares · 17,012 shares Expires 2035-06-04 F1 · derivative.exercise_date: Vesting 100% on the earlier of (i) June 4, 2026 or (ii) the day before the date of the issuer's 2026 annual meeting of shareholders. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 21:57 UTC |
Cannon GillianDirector
|
GrantRestricted Share Units · Derivative | 2,645 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-083318 · ownership.xml · derivative · entry 2 Cannon Gillian · CIK 0001833910 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,645 Underlying: Common Shares · 2,645 shares Expires not disclosed F2 · derivative.exercise_date: Each restricted share unit represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 4, 2026 or (ii) the day before the date of the issuer's 2026 annual meeting of shareholders. F2 · derivative.expiration_date: Each restricted share unit represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 4, 2026 or (ii) the day before the date of the issuer's 2026 annual meeting of shareholders. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 21:57 UTC |
Cannon GillianDirector
|
GrantShare Option (Right to Buy) · Derivative | 17,012 | $0.00 Strike: $30.73 | $0.00 |
DisclosureSEC source: 0000950170-25-083318 · ownership.xml · derivative · entry 1 Cannon Gillian · CIK 0001833910 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,012 Underlying: Common Shares · 17,012 shares Expires 2035-06-04 F1 · derivative.exercise_date: Vesting 100% on the earlier of (i) June 4, 2026 or (ii) the day before the date of the issuer's 2026 annual meeting of shareholders. Read SEC document |
| May 14, 2025 Filed May 16, 2025 21:59 UTC |
GANNON STEVENDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,144 | $0.00 Strike: $12.57 | $0.00 |
DisclosureSEC source: 0000950170-25-073746 · ownership.xml · derivative · entry 2 GANNON STEVEN · CIK 0001643085 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 5,144 shares Expires 2025-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| May 14, 2025 Filed May 16, 2025 21:59 UTC |
GANNON STEVENDirector
|
Exercise / conversionCommon Shares | 5,144 | $12.57 | $64,660.08 |
DisclosureSEC source: 0000950170-25-073746 · ownership.xml · nonDerivative · entry 1 GANNON STEVEN · CIK 0001643085 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,144 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2025 Filed Mar 13, 2025 23:31 UTC |
KENNEY CHRISTOPHER JOHNChief Medical Officer
|
GrantRestricted Share Units · Derivative | 15,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-039021 · ownership.xml · derivative · entry 2 KENNEY CHRISTOPHER JOHN · CIK 0001880129 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Shares · 15,000 shares Expires not disclosed F2 · derivative.exercise_date: Each restricted share unit represents a contingent right to receive one Common Share vesting 25% on each of the first four anniversaries of the date of grant, beginning on March 12, 2026. F2 · derivative.expiration_date: Each restricted share unit represents a contingent right to receive one Common Share vesting 25% on each of the first four anniversaries of the date of grant, beginning on March 12, 2026. Read SEC document |
| March 12, 2025 Filed Mar 13, 2025 23:31 UTC |
KENNEY CHRISTOPHER JOHNChief Medical Officer
|
GrantShare Option (Right to Buy) · Derivative | 80,000 | $0.00 Strike: $35.48 | $0.00 |
DisclosureSEC source: 0000950170-25-039021 · ownership.xml · derivative · entry 1 KENNEY CHRISTOPHER JOHN · CIK 0001880129 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Shares · 80,000 shares Expires 2035-03-11 F1 · derivative.exercise_date: Vesting 25% on March 12, 2026, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month. Read SEC document |
| March 12, 2025 Filed Mar 13, 2025 19:30 UTC |
DiFabio AndreaChief Legal Officer
|
GrantRestricted Share Units · Derivative | 15,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-039020 · ownership.xml · derivative · entry 2 DiFabio Andrea · CIK 0001692506 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Shares · 15,000 shares Expires not disclosed F2 · derivative.exercise_date: Each restricted share unit represents a contingent right to receive one Common Share vesting 25% on each of the first four anniversaries of the date of grant, beginning on March 12, 2026. F2 · derivative.expiration_date: Each restricted share unit represents a contingent right to receive one Common Share vesting 25% on each of the first four anniversaries of the date of grant, beginning on March 12, 2026. Read SEC document |
| March 12, 2025 Filed Mar 13, 2025 19:30 UTC |
DiFabio AndreaChief Legal Officer
|
GrantShare Option (Right to Buy) · Derivative | 80,000 | $0.00 Strike: $35.48 | $0.00 |
DisclosureSEC source: 0000950170-25-039020 · ownership.xml · derivative · entry 1 DiFabio Andrea · CIK 0001692506 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Shares · 80,000 shares Expires 2035-03-11 F1 · derivative.exercise_date: Vesting 25% on March 12, 2026, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month. Read SEC document |
| March 12, 2025 Filed Mar 13, 2025 23:33 UTC |
MORTIMER IANDirector · PRESIDENT & CEO
|
GrantRestricted Share Units · Derivative | 50,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-039025 · ownership.xml · derivative · entry 2 MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Shares · 50,000 shares Expires not disclosed F2 · derivative.exercise_date: Each restricted share unit represents a contingent right to receive one Common Share vesting 25% on each of the first four anniversaries of the date of grant, beginning on March 12, 2026. F2 · derivative.expiration_date: Each restricted share unit represents a contingent right to receive one Common Share vesting 25% on each of the first four anniversaries of the date of grant, beginning on March 12, 2026. Read SEC document |
| March 12, 2025 Filed Mar 13, 2025 23:33 UTC |
MORTIMER IANDirector · PRESIDENT & CEO
|
GrantShare Option (Right to Buy) · Derivative | 275,000 | $0.00 Strike: $35.48 | $0.00 |
DisclosureSEC source: 0000950170-25-039025 · ownership.xml · derivative · entry 1 MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 275,000 Underlying: Common Shares · 275,000 shares Expires 2035-03-11 F1 · derivative.exercise_date: Vesting 25% on March 12, 2026, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month. Read SEC document |
| January 27, 2025 Filed Jan 28, 2025 01:28 UTC |
MORTIMER IANDirector · PRESIDENT & CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 16,315 | $0.00 Strike: $17.76 | $0.00 |
DisclosureSEC source: 0000950170-25-009388 · ownership.xml · derivative · entry 12 MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 16,315 shares Expires 2025-03-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| January 27, 2025 Filed Jan 28, 2025 01:28 UTC |
MORTIMER IANDirector · PRESIDENT & CEO
|
SaleCommon Shares | 1,149 | $41.07 | $47,189.43 |
DisclosureSEC source: 0000950170-25-009388 · ownership.xml · nonDerivative · entry 8 MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,302 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2024. F5 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, of shares sold. These share were sold in multiple transactions at prices ranging from $41.01 to $41.145, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| January 27, 2025 Filed Jan 28, 2025 01:28 UTC |
MORTIMER IANDirector · PRESIDENT & CEO
|
Exercise / conversionCommon Shares | 1,149 | $17.76 | $20,406.24 |
DisclosureSEC source: 0000950170-25-009388 · ownership.xml · nonDerivative · entry 7 MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,451 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 27, 2025 Filed Jan 28, 2025 01:28 UTC |
MORTIMER IANDirector · PRESIDENT & CEO
|
SaleCommon Shares | 15,166 | $40.46 | $613,616.36 |
DisclosureSEC source: 0000950170-25-009388 · ownership.xml · nonDerivative · entry 6 MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,302 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2024. F4 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, of shares sold. These share were sold in multiple transactions at prices ranging from $40.00 to $40.99, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| January 27, 2025 Filed Jan 28, 2025 01:28 UTC |
MORTIMER IANDirector · PRESIDENT & CEO
|
Exercise / conversionCommon Shares | 15,166 | $17.76 | $269,348.16 |
DisclosureSEC source: 0000950170-25-009388 · ownership.xml · nonDerivative · entry 5 MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 46,468 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 24, 2025 Filed Jan 28, 2025 01:28 UTC |
MORTIMER IANDirector · PRESIDENT & CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 22,468 | $0.00 Strike: $17.76 | $0.00 |
DisclosureSEC source: 0000950170-25-009388 · ownership.xml · derivative · entry 11 MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,315 Underlying: Common Shares · 22,468 shares Expires 2025-03-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| January 24, 2025 Filed Jan 28, 2025 01:28 UTC |
MORTIMER IANDirector · PRESIDENT & CEO
|
SaleCommon Shares | 22,468 | $40.20 | $903,213.60 |
DisclosureSEC source: 0000950170-25-009388 · ownership.xml · nonDerivative · entry 4 MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,302 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2024. F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, of shares sold. These share were sold in multiple transactions at prices ranging from $40.00 to $40.535, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| January 24, 2025 Filed Jan 28, 2025 01:28 UTC |
MORTIMER IANDirector · PRESIDENT & CEO
|
Exercise / conversionCommon Shares | 22,468 | $17.76 | $399,031.68 |
DisclosureSEC source: 0000950170-25-009388 · ownership.xml · nonDerivative · entry 3 MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,770 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 23, 2025 Filed Jan 28, 2025 01:28 UTC |
MORTIMER IANDirector · PRESIDENT & CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 16,217 | $0.00 Strike: $17.76 | $0.00 |
DisclosureSEC source: 0000950170-25-009388 · ownership.xml · derivative · entry 10 MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,783 Underlying: Common Shares · 16,217 shares Expires 2025-03-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| January 23, 2025 Filed Jan 28, 2025 01:28 UTC |
MORTIMER IANDirector · PRESIDENT & CEO
|
SaleCommon Shares | 16,217 | $40.08 | $649,977.36 |
DisclosureSEC source: 0000950170-25-009388 · ownership.xml · nonDerivative · entry 2 MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,302 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2024. F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, of shares sold. These share were sold in multiple transactions at prices ranging from $40.00 to $40.24, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| January 23, 2025 Filed Jan 28, 2025 01:28 UTC |
MORTIMER IANDirector · PRESIDENT & CEO
|
Exercise / conversionCommon Shares | 16,217 | $17.76 | $288,013.92 |
DisclosureSEC source: 0000950170-25-009388 · ownership.xml · nonDerivative · entry 1 MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 47,519 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 18, 2024 Filed Dec 19, 2024 18:57 UTC |
AULIN SHERRYChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 16,000 | $0.00 Strike: $11.58 | $0.00 |
DisclosureSEC source: 0000950170-24-138629 · ownership.xml · derivative · entry 8 AULIN SHERRY · CIK 0001862144 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Shares · 16,000 shares Expires 2030-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| December 18, 2024 Filed Dec 19, 2024 18:57 UTC |
AULIN SHERRYChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 9,334 | $0.00 Strike: $9.44 | $0.00 |
DisclosureSEC source: 0000950170-24-138629 · ownership.xml · derivative · entry 7 AULIN SHERRY · CIK 0001862144 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 9,334 shares Expires 2029-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| December 18, 2024 Filed Dec 19, 2024 18:57 UTC |
AULIN SHERRYChief Financial Officer
|
SaleCommon Shares | 11,510 | $41.19 | $474,096.90 |
DisclosureSEC source: 0000950170-24-138629 · ownership.xml · nonDerivative · entry 6 AULIN SHERRY · CIK 0001862144 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $41.19 to $41.20, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| December 18, 2024 Filed Dec 19, 2024 18:57 UTC |
AULIN SHERRYChief Financial Officer
|
Tax withholdingCommon Shares | 4,490 | $41.28 | $185,347.20 |
DisclosureSEC source: 0000950170-24-138629 · ownership.xml · nonDerivative · entry 5 AULIN SHERRY · CIK 0001862144 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,510 F1 · price: Represents the closing price of the Company's common shares on December 17, 2024 for purposes of net settlement calculations. Read SEC document |
| December 18, 2024 Filed Dec 19, 2024 18:57 UTC |
AULIN SHERRYChief Financial Officer
|
Exercise / conversionCommon Shares | 16,000 | $11.58 | $185,280.00 |
DisclosureSEC source: 0000950170-24-138629 · ownership.xml · nonDerivative · entry 4 AULIN SHERRY · CIK 0001862144 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 18, 2024 Filed Dec 19, 2024 18:57 UTC |
AULIN SHERRYChief Financial Officer
|
SaleCommon Shares | 7,199 | $41.23 | $296,814.77 |
DisclosureSEC source: 0000950170-24-138629 · ownership.xml · nonDerivative · entry 3 AULIN SHERRY · CIK 0001862144 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| December 18, 2024 Filed Dec 19, 2024 18:57 UTC |
AULIN SHERRYChief Financial Officer
|
Tax withholdingCommon Shares | 2,135 | $41.28 | $88,132.80 |
DisclosureSEC source: 0000950170-24-138629 · ownership.xml · nonDerivative · entry 2 AULIN SHERRY · CIK 0001862144 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,199 F1 · price: Represents the closing price of the Company's common shares on December 17, 2024 for purposes of net settlement calculations. Read SEC document |
| December 18, 2024 Filed Dec 19, 2024 18:57 UTC |
AULIN SHERRYChief Financial Officer
|
Exercise / conversionCommon Shares | 9,334 | $9.44 | $88,112.96 |
DisclosureSEC source: 0000950170-24-138629 · ownership.xml · nonDerivative · entry 1 AULIN SHERRY · CIK 0001862144 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 22, 2024 Filed Nov 23, 2024 00:48 UTC |
PATOU GARYDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,086 | $0.00 Strike: $13.48 | $0.00 |
DisclosureSEC source: 0000950170-24-130378 · ownership.xml · derivative · entry 9 PATOU GARY · CIK 0001283535 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 3,086 shares Expires 2025-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| November 22, 2024 Filed Nov 23, 2024 00:48 UTC |
PATOU GARYDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,500 | $0.00 Strike: $7.38 | $0.00 |
DisclosureSEC source: 0000950170-24-130378 · ownership.xml · derivative · entry 8 PATOU GARY · CIK 0001283535 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 3,500 shares Expires 2026-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| November 22, 2024 Filed Nov 23, 2024 00:48 UTC |
PATOU GARYDirector
|
SaleCommon Shares | 2,040 | $41.05 | $83,742.00 |
DisclosureSEC source: 0000950170-24-130378 · ownership.xml · nonDerivative · entry 6 PATOU GARY · CIK 0001283535 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,573 Read SEC document |
| November 22, 2024 Filed Nov 23, 2024 00:48 UTC |
PATOU GARYDirector
|
Tax withholdingCommon Shares | 1,046 | $39.80 | $41,630.80 |
DisclosureSEC source: 0000950170-24-130378 · ownership.xml · nonDerivative · entry 5 PATOU GARY · CIK 0001283535 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,613 F1 · price: Represents the closing price of the Company's common shares on November 21, 2024 for purposes of net settlement calculations. Read SEC document |
| November 22, 2024 Filed Nov 23, 2024 00:48 UTC |
PATOU GARYDirector
|
Exercise / conversionCommon Shares | 3,086 | $13.48 | $41,599.28 |
DisclosureSEC source: 0000950170-24-130378 · ownership.xml · nonDerivative · entry 4 PATOU GARY · CIK 0001283535 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,659 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 22, 2024 Filed Nov 23, 2024 00:48 UTC |
PATOU GARYDirector
|
SaleCommon Shares | 2,851 | $41.11 | $117,204.61 |
DisclosureSEC source: 0000950170-24-130378 · ownership.xml · nonDerivative · entry 3 PATOU GARY · CIK 0001283535 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,573 Read SEC document |
| November 22, 2024 Filed Nov 23, 2024 00:48 UTC |
PATOU GARYDirector
|
Tax withholdingCommon Shares | 649 | $39.80 | $25,830.20 |
DisclosureSEC source: 0000950170-24-130378 · ownership.xml · nonDerivative · entry 2 PATOU GARY · CIK 0001283535 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,424 F1 · price: Represents the closing price of the Company's common shares on November 21, 2024 for purposes of net settlement calculations. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.